Parminder P. Singh
Advanced in Arterial Embolism

Dr. Parminder P. Singh

Cardiology | Interventional Cardiology
CommonSpirit Health
Heart And Vascular Center Of Arizona, PC
1331 N 7th St, Ste 375, 
Phoenix, AZ 
Accepting New Patients
Offers Telehealth

Advanced in Arterial Embolism
CommonSpirit Health
Heart And Vascular Center Of Arizona, PC
1331 N 7th St, Ste 375, 
Phoenix, AZ 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

To help people achieve health for life.

Dr. Singh is rated as an Advanced provider by MediFind in the treatment of Arterial Embolism. His top areas of expertise are Arterial Embolism, Angina, Carotid Artery Disease, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR).

His clinical research consists of co-authoring 55 peer reviewed articles and participating in 11 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
Government Medical College, Amritsar
Residency
Government Medical College
Specialties
Cardiology
Interventional Cardiology
Licenses
Internal Medicine in AZ
Board Certifications
Internal Medicine
Internal Medicine (Sub: Cardiovascular Disease)
Internal Medicine (Sub: Interventional Cardiology)
Fellowships
Albany Medical Center
Detroit Receiving Hospital
Hospital Affiliations
Banner Estrella Medical Center
Banner Boswell Medical Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Alignment Health Plan
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
MercyCare
  • EPO
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
VibrantRx
  • MEDICARE PDP
  • OTHER MEDICARE
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 15 Less Insurance Carriers -

Locations

Heart and Vascular Center of Arizona, PC
1331 N 7th St, Ste 375, Phoenix, AZ 85006
Call: 602-307-0070

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


11 Clinical Trials

A Pilot Study of Tazemetostat and Pembrolizumab (MK-3475) in Advanced Urothelial Carcinoma
A Pilot Study of Tazemetostat and Pembrolizumab (MK-3475) in Advanced Urothelial Carcinoma
Enrollment Status: Active_not_recruiting
Publish Date: December 17, 2025
Intervention Type: Procedure, Drug, Biological
Study Drugs: Pembrolizumab, Tazemetostat
Study Phase: Phase 1/Phase 2
Phase III Randomized Trial of Concurrent Chemoradiotherapy With or Without Atezolizumab in Localized Muscle Invasive Bladder Cancer
Phase III Randomized Trial of Concurrent Chemoradiotherapy With or Without Atezolizumab in Localized Muscle Invasive Bladder Cancer
Enrollment Status: Active_not_recruiting
Publish Date: November 20, 2025
Intervention Type: Other, Procedure, Drug, Radiation
Study Drugs: Atezolizumab, Cisplatin, Fluorouracil, Gemcitabine, Mitomycin C
Study Phase: Phase 3
Phase III Randomized Adjuvant Study of Pembrolizumab in muScle invaSive and locAlly aDvanced urOthelial caRcinoma (AMBASSADOR) Versus Observation
Phase III Randomized Adjuvant Study of Pembrolizumab in muScle invaSive and locAlly aDvanced urOthelial caRcinoma (AMBASSADOR) Versus Observation
Enrollment Status: Active_not_recruiting
Publish Date: November 17, 2025
Intervention Type: Other, Biological, Procedure
Study Drug: Pembrolizumab
Study Phase: Phase 3
Phase II Trial of Atezolizumab in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
Phase II Trial of Atezolizumab in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
Enrollment Status: Completed
Publish Date: May 22, 2025
Intervention Type: Drug
Study Drug: Atezolizumab
Study Phase: Phase 2
A Phase III Randomized Trial Comparing Androgen Deprivation Therapy + TAK-700 With Androgen Deprivation Therapy + Bicalutamide in Patients With Newly Diagnosed Metastatic Sensitive Prostate Cancer
A Phase III Randomized Trial Comparing Androgen Deprivation Therapy + TAK-700 With Androgen Deprivation Therapy + Bicalutamide in Patients With Newly Diagnosed Metastatic Sensitive Prostate Cancer
Enrollment Status: Active_not_recruiting
Publish Date: March 19, 2025
Intervention Type: Drug
Study Drugs: TAK-700, Bicalutamide
Study Phase: Phase 3
A Randomized Phase 2 Trial of Cisplatin/Gemcitabine With or Without M6620 (VX-970) in Metastatic Urothelial Carcinoma
A Randomized Phase 2 Trial of Cisplatin/Gemcitabine With or Without M6620 (VX-970) in Metastatic Urothelial Carcinoma
Enrollment Status: Completed
Publish Date: March 03, 2025
Intervention Type: Drug
Study Drugs: Berzosertib, Cisplatin, Gemcitabine Hydrochloride
Study Phase: Phase 2
Dose Escalation and Expansion Clinical Study to Evaluate the Safety and Efficacy of ELU001 in Subjects Who Have Advanced, Recurrent or Refractory FRα Overexpressing Tumors
Dose Escalation and Expansion Clinical Study to Evaluate the Safety and Efficacy of ELU001 in Subjects Who Have Advanced, Recurrent or Refractory FRα Overexpressing Tumors
Enrollment Status: Terminated
Publish Date: August 07, 2024
Intervention Type: Drug
Study Drug: ELU001
Study Phase: Phase 1/Phase 2
Phase 1 Study With Expansion Cohorts to Assess the Safety, Tolerability, and Activity of Oraxol (Paclitaxel + HM30181A) in Combination With Pembrolizumab in Subjects With Advanced Solid Malignancies
Phase 1 Study With Expansion Cohorts to Assess the Safety, Tolerability, and Activity of Oraxol (Paclitaxel + HM30181A) in Combination With Pembrolizumab in Subjects With Advanced Solid Malignancies
Enrollment Status: Terminated
Publish Date: May 19, 2023
Intervention Type: Drug, Biological
Study Phase: Phase 1
A Randomized Phase III Double Blinded Placebo Controlled Trial of Aspirin as Adjuvant Therapy for HER2 Negative Breast Cancer: The ABC Trial
A Randomized Phase III Double Blinded Placebo Controlled Trial of Aspirin as Adjuvant Therapy for HER2 Negative Breast Cancer: The ABC Trial
Enrollment Status: Terminated
Publish Date: April 05, 2023
Intervention Type: Other, Drug
Study Drug: Aspirin
Study Phase: Phase 3
Phase II Study Evaluating Combination Chemotherapy + Radiotherapy (RT) With Avelumab in Muscle Invasive Bladder Cancer
Phase II Study Evaluating Combination Chemotherapy + Radiotherapy (RT) With Avelumab in Muscle Invasive Bladder Cancer
Enrollment Status: Completed
Publish Date: January 06, 2023
Intervention Type: Other, Radiation, Drug
Study Drugs: Avelumab, Cisplatin, 5-Fluorouracil, Mitomycin C
Study Phase: Phase 2
Proleukin Observational Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
Proleukin Observational Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
Enrollment Status: Completed
Publish Date: June 13, 2019
View 10 Less Clinical Trials

55 Total Publications

Circulating Tumor DNA in Urothelial Cancer: Practical Applications in Oncology Clinic.
Circulating Tumor DNA in Urothelial Cancer: Practical Applications in Oncology Clinic.
Journal: JCO oncology practice
Published: December 16, 2025
View All 55 Publications
Similar Doctors
Zaki Lababidi
Distinguished in Arterial Embolism
Dr. Zaki Lababidi
Cardiology | Interventional Cardiology
Distinguished in Arterial Embolism
Dr. Zaki Lababidi
Cardiology | Interventional Cardiology

Gilbert Cardiology

3505 S Mercy Rd, 
Gilbert, AZ 
 (21.8 miles away)
480-786-9100
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Zaki Lababidi is a Cardiologist and an Interventional Cardiologist in Gilbert, Arizona. Dr. Lababidi is rated as a Distinguished provider by MediFind in the treatment of Arterial Embolism. His top areas of expertise are Atherosclerosis, Coronary Heart Disease, Angina, and Arterial Embolism. Dr. Lababidi is currently accepting new patients.

Distinguished in Arterial Embolism
Dr. Pradeep Bhat
Cardiology
Distinguished in Arterial Embolism
Dr. Pradeep Bhat
Cardiology

Cardiovascular Consultants

3805 E Bell Rd Ste 3100, 
Phoenix, AZ 
 (11.8 miles away)
602-867-8644
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Pradeep Bhat is a Cardiologist in Phoenix, Arizona. Dr. Bhat is rated as a Distinguished provider by MediFind in the treatment of Arterial Embolism. His top areas of expertise are Atrial Fibrillation, Arterial Embolism, Heart Failure, and Coronary Heart Disease.

Nathan Laufer
Distinguished in Arterial Embolism
Dr. Nathan Laufer
Cardiology | Interventional Cardiology
Distinguished in Arterial Embolism
Dr. Nathan Laufer
Cardiology | Interventional Cardiology

Heart And Vascular Center Of Arizona, PC

1331 N 7th St, Ste 375, 
Phoenix, AZ 
 (0.1 miles away)
602-307-0070
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Nathan Laufer MDCM, is originally from Montreal, Canada. He is medical graduate from McGill University, class of 1977. His internal medicine residency was completed at the University of Toronto, 1977-81, and his cardiology fellowship at the University of Michigan, 1981-83, where he remained on faculty prior to moving to Phoenix. Within one year of arriving, he became the Coronary Care Unit Director at Good Samaritan Hospital, a University of Arizona teaching hospital. He is board certified in Internal Medicine and Cardiology in Canada and the US, and board certified in Interventional Cardiology by the ABIM.He has been practicing and teaching cardiology in Phoenix for over 35 years. He is the founder and medical director of the Heart & Vascular Center of Arizona. He is past program director and founder of the 4th year Interventional Cardiology Fellowship at Banner Good Samaritan Hospital, founder of the Cardiovascular Society of Arizona, and past Chief, Department of Cardiovascular Disease Banner Estrella Medical Center in Phoenix.He is past President of the Arizona Medical Association. Over the years he has held numerous board positions including president of the Maricopa County Medical Society, president of the Phoenix Board of the American Heart Association, Counselor of the Arizona Chapter of the American College of Cardiology, and Board Member of the University of Michigan Club Of Greater Phoenix.He has received numerous awards including McGill University Scholarships, Teacher of the Year at Good Samaritan Hospital, and National Leadership Award, Wings of Memory, US Holocaust Memorial Museum. He is listed in Who's Who in America, 1998-2018; Phoenix Business Journal Survey of Most Influential in Health Care; Top Doc-Cardiovascular Disease, Phoenix Magazine 1998-2018; Best Doctors in America 2007-18; and numerous other listings.He has lectured all over the US, Russia, and Japan. He organized technique workshops and medical conferences on angioplasty, stenting, and rotablator technology and other aspects of cardiology. He has 98 publications to his credit, many in the field of Interventional Cardiology.He has also participated in numerous charitable activities including US Holocaust Memorial Museum, Anti-Defamation League, Phoenix Symphony, AJC, United Way's Alexis de Tocqueville Society, King David School, JNF, Friends of the IDF, and AIPAC.His wife, Judy, is also from Montreal, was a kindergarten teacher in the West Island and currently a children's book author. They married in 1986 and have one son, Andrew, currently living in Los Angeles.We provide comprehensive care including prevention, diagnosis, and treatment of coronary, vascular, and carotid disease, as well as arrhythmias, and women's cardiology. Dr. Laufer is rated as a Distinguished provider by MediFind in the treatment of Arterial Embolism. His top areas of expertise are Carotid Artery Disease, Arterial Embolism, Familial Combined Hyperlipidemia, and Xanthoma.

VIEW MORE ARTERIAL EMBOLISM DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Singh's expertise for a condition
ConditionClose
      • Advanced
      • Adenosine Deaminase 2 Deficiency
        Dr. Singh is
        Advanced
        . Learn about Adenosine Deaminase 2 Deficiency.
        See more Adenosine Deaminase 2 Deficiency experts
      • Angina
        Dr. Singh is
        Advanced
        . Learn about Angina.
        See more Angina experts
      • Apoplexy
        Dr. Singh is
        Advanced
        . Learn about Apoplexy.
        See more Apoplexy experts
      • Arterial Embolism
        Dr. Singh is
        Advanced
        . Learn about Arterial Embolism.
        See more Arterial Embolism experts
      • Atherosclerosis
        Dr. Singh is
        Advanced
        . Learn about Atherosclerosis.
        See more Atherosclerosis experts
      • Atrial Fibrillation
        Dr. Singh is
        Advanced
        . Learn about Atrial Fibrillation.
        See more Atrial Fibrillation experts
      View All 23 Advanced Conditions
      • Experienced
      • Acute Coronary Syndrome
        Dr. Singh is
        Experienced
        . Learn about Acute Coronary Syndrome.
        See more Acute Coronary Syndrome experts
      • Aortic Regurgitation
        Dr. Singh is
        Experienced
        . Learn about Aortic Regurgitation.
        See more Aortic Regurgitation experts
      • Aortic Valve Replacement
        Dr. Singh is
        Experienced
        . Learn about Aortic Valve Replacement.
        See more Aortic Valve Replacement experts
      • Aortic Valve Stenosis
        Dr. Singh is
        Experienced
        . Learn about Aortic Valve Stenosis.
        See more Aortic Valve Stenosis experts
      • Arrhythmias
        Dr. Singh is
        Experienced
        . Learn about Arrhythmias.
        See more Arrhythmias experts
      • Arrhythmogenic Right Ventricular Cardiomyopathy
        Dr. Singh is
        Experienced
        . Learn about Arrhythmogenic Right Ventricular Cardiomyopathy.
        See more Arrhythmogenic Right Ventricular Cardiomyopathy experts
      View All 62 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile
      For Patients
      • Our Story
      • How MediFind Works
      • Conditions A-Z
      • Doctor Directory
      • Symptoms Directory
      • Procedures Directory
      • Treatment Directory
      • Drug Directory
      • Infusion Center Finder
      • FAQ
      • Contact Us
      For Providers and Practices
      • Claim Your Profile
      • Newsroom
      Business Solutions
      • Provider
      • Network Solutions
      Additional Resources
      • Consumer Health Data Privacy Policy
      • Privacy Policy
      • Terms of Use
      • Advertising Policy
      • Content Policy
      Subscribe to our newsletter

      Sign up to stay informed about MediFind and get wellness sent your way.

      Close

        By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

        Bullet PinMediFind
        Follow us on
        This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
        © 2026 All Rights Reserved

        Request an Appointment

        If you are experiencing a medical emergency, call 9-1-1.

        MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

        Patient Details

        This information is for the patient who will be seen at the appointment.

          Close

          Returning patient? Use your address on file with the provider.

          Insurance Details

          Please provide information of the primary insurance holder as the practice may require this information to schedule.

          Insurance Provider *
          Insurance ProviderClose

          Appointments Details

          Let’s get more information about your appointment.

                  0 / 1000
                  0 / 1000
                  By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.